AzTrials
AzTrials

Carpal Tunnel Syndrome (CTS)NCT07170449

Investigation of the Relationship Between Ultrasonographic Parameters and Tactile Sensation in Carpal Tunnel Syndrome

An observational study of Carpal Tunnel Syndrome (CTS), run by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The aim of this study was to investigate the relationship between different ultrasonographic indices used in patients with carpal tunnel syndrome and the level of tactile sensation. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Carpal Tunnel Syndrome (CTS)
What is being tested?
Nerve conduction studies, Median nerve ultrasonography and Sensory testing
How many people
84 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Aug 2025to 30 Apr 2026
How long will I take part?
3 Months
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients with diagnosed CTS

Who may be able to join

  • Electrodiagnostic diagnosis of carpal tunnel syndrome with pain, numbness, burning, and tingling consistent with the median nerve dermatomal area lasting at least 6 weeks.
  • Literate
  • Agree to participate in the study

Who cannot join

  • Concomitant diabetes, systemic inflammatory disease, active infection, and history of malignancy
  • Being <18 and >65 years old
  • Being illiterate
  • Refusing to participate in the study
  • Having a disease with neuropathic pain, such as polyneuropathy, radiculopathy, or MS
  • Other concomitant upper extremity entrapment neuropathies (e.g., cubital tunnel syndrome)
  • Having undergone surgery for carpal tunnel syndrome
  • Rheumatoid arthritis, advanced hand osteoarthritis

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Müyesser Cavlak, PhD contact

+905426406118

muyessercavlak@hotmail.com

Feyza Nur Yücel, Specialist contact

5385577059 ext +90

dr.fny28@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Sultan Abdülhamit Han Trainin and Educational Hospital

    Üsküdar, İ̇stanbul

    Müyesser Cavlak, PhD, +905426406118, muyessercavlak@hotmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

The aim of this study was to investigate the relationship between different ultrasonographic indices used in patients with carpal tunnel syndrome and the level of tactile sensation.

The primary questions the study aimed to answer are:

  • To what extent are the ultrasonographic parameters used in the diagnosis of carpal tunnel syndrome related to the level of sensory complaints in the patient?
Read the detailed description

Carpal tunnel syndrome (CTS) is the most common compression neuropathy. The etiology of CTS can be related to work, lifestyle, injury, or genetic predisposition. Exposure to vibrations or repetitive forceful angular movements is among the most common causes of CTS. Certain diseases, such as diabetes, pregnancy, and morbidity, are also thought to be associated with an increased risk of developing CTS. It accounts for 90% of all entrapment neuropathies. Its prevalence in the population is between 1% and 5%, and it is three times more common in women. In CTS, complaints related to motor and sensory deficits are observed in the first three fingers innervated by the median nerve and the radial aspect of the fourth finger. Diagnosis is made by corroborating clinical signs and symptoms with electrophysiological findings. However, recently, ultrasound (US) is frequently preferred for the diagnosis of CTS to evaluate the morphological and mechanical properties of the median nerve. US is considered a highly accurate, effective, and cost-effective diagnostic method for the diagnosis of CTS, with a short evaluation time . Sonographic measurements related to CTS can yield values such as the diameter of the nerve at the entrance and exit of the tunnel. CTS presents with a disturbance in tactile input, such as numbness and loss of sensation in the median nerve dermatom. This sensory loss can cause difficulty in using the patient's hand in activities of daily living. Sonography has recently become widely used in CTS patients. The fact that values measured by sonography can provide information about the clinical status of patients can be considered important data for healthcare professionals. Therefore, our study was designed to examine the relationship between sonographic measurements and tactile sensory levels in patients diagnosed with mild to moderate CTS based on electrodiagnostic tests.

Being tested
Nerve conduction studies, Median nerve ultrasonography, Sensory testing
Keywords
Carpal Tunnel Syndrome, Ultrasonography, Tactile Sensation
Medical subject headings
Carpal Tunnel Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Nerve conduction studiesDiagnostic test

    Upper extremity nerve conduction studies including median-ulnar sensory and motor responses

  • Median nerve ultrasonographyDiagnostic test

    Median nerve sonographic cross-sectional area and echogenicity measurements

  • Sensory testingDiagnostic test

    tactile sensory tests

Study groups in NCT07170449
Study groupRoleWhat they receive
Patient groupPatients with carpal tunnel syndrome
Receives: Diagnostic Test: Nerve conduction studies; Diagnostic Test: Median nerve ultrasonography; Diagnostic Test: Sensory testing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. median nerve ultrasound

    Median nerve maximum cross-sectional area measurement at the level of the carpal tunnel (mm²)

    Measured: 3 Months

  2. Pointed - blunt discrimination test

    The patient is asked to distinguish between a pointed and a blunt tip by touching the median nerve dermatome.

    Measured: 3 Months

  3. Moved two point discrimination

    The patient's finger is touched, starting from the distal tip and moving proximally, and the patient is asked to distinguish between one and two dots. The distance between the last pair of dots the patient can distinguish is noted in mm.

    Measured: 3 months

  4. Fixed Two Point Discrimination Test

    The patient's finger is touched starting from the distal tip and working proximally, and the patient is asked to distinguish between one and two dots. The distance between the last pair of dots the patient can distinguish is noted in millimeters.

    Measured: 3 months

  5. Semmes Weinstein Test

    With the patient's eyes closed, monofilament is applied perpendicularly in a steady manner until the filament bends. Use a smooth motion to touch the skin with the filament, bend the filament for a full second, than lift from the skin. Patient raises hand to indicate that the monofilament touch sensation is perceived.

    Measured: 3 months

  6. median nerve ultrasound

    Median nerve echogenicity at the level of the carpal tunnel (%)

    Measured: 3 months

  7. median nerve ultrasound

    Median nerve cross-sectional area measurement at the level of the carpal tunnel inlet (mm²)

    Measured: 3 months

  8. median nerve ultrasound

    Median nerve cross-sectional area measurement at the level of the carpal tunnel outlet (mm²)

    Measured: 3 months

  9. median nerve ultrasound

    Median nerve cross-sectional area measurement at the level of the pronator quadratus (mm²)

    Measured: 3 months

Secondary outcomes (3)
  1. Boston Carpal Tunnel Syndrome Questionnaire

    The scale consists of an 11-question Likert-style symptom severity scale and an 8-question functional status scale. The total score is divided by the number of questions to calculate the score. Higher scores are associated with increased symptom severity and poorer functional status.

    Measured: 3 Months

  2. S-LANSS

    A score of 12 or more out of 24 on a 7-question scale is considered in favor of neuropathic pain.

    Measured: 3 Months

  3. SF-12 (Short Form-12)

    The SF-12 is a practical test consisting of seven questions that examine the life limits of the patient. The questionnaire includes questions aimed at understanding the physical and psychiatric effects. The results of the survey are calculated using two score calculation tools: physical (PCS-12) and mental (MCS-12). The highest score for the PCS-12 is 56.6, while the highest score for the MCS-12 is 60.7. Higher scores are comparable to a state of resilience and recovery, which can be compared to quality of life.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Sep 2025
  2. Study start1 Aug 2025
  3. Primary completion1 Apr 2026 (estimated)
  4. Study completion30 Apr 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
84 participants (estimated)
Target duration
3 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT07170449
Sponsor's protocol ID
Sultan Abdulhamid Han
Status last verified
Sep 2025
First submitted
5 Sep 2025
Last updated
12 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Bennett MI, Smith BH, Torrance N, Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. J Pain. 2005 Mar;6(3):149-58. doi: 10.1016/j.jpain.2004.11.007.

    PubMed 15772908
  • Sezgin M, Incel NA, Serhan S, Camdeviren H, As I, Erdogan C. Assessment of symptom severity and functional status in patients with carpal tunnel syndrome: reliability and functionality of the Turkish version of the Boston Questionnaire. Disabil Rehabil. 2006 Oct 30;28(20):1281-5. doi: 10.1080/09638280600621469.

    PubMed 17083175
  • Multanen J, Ylinen J, Karjalainen T, Ikonen J, Hakkinen A, Repo JP. Structural validity of the Boston Carpal Tunnel Questionnaire and its short version, the 6-Item CTS symptoms scale: a Rasch analysis one year after surgery. BMC Musculoskelet Disord. 2020 Sep 12;21(1):609. doi: 10.1186/s12891-020-03626-2.

    PubMed 32919457
  • Stevens JC. AAEE minimonograph #26: The electrodiagnosis of carpal tunnel syndrome. Muscle Nerve. 1987 Feb;10(2):99-113. doi: 10.1002/mus.880100202.

    PubMed 3821791
  • Fisse AL, Pitarokoili K, Motte J, Gamber D, Kerasnoudis A, Gold R, Yoon MS. Nerve echogenicity and intranerve CSA variability in high-resolution nerve ultrasound (HRUS) in chronic inflammatory demyelinating polyneuropathy (CIDP). J Neurol. 2019 Feb;266(2):468-475. doi: 10.1007/s00415-018-9158-3. Epub 2018 Dec 15.

    PubMed 30554264
  • Wolny T, Linek P. Reliability of two-point discrimination test in carpal tunnel syndrome patients. Physiother Theory Pract. 2019 Apr;35(4):348-354. doi: 10.1080/09593985.2018.1443358. Epub 2018 Feb 26.

    PubMed 29482409
  • Kim JM, Kim MW, Ko YJ. Correlating ultrasound findings of carpal tunnel syndrome with nerve conduction studies. Muscle Nerve. 2013 Dec;48(6):905-10. doi: 10.1002/mus.23841. Epub 2013 Sep 11.

    PubMed 23512486
  • Aboonq MS. Pathophysiology of carpal tunnel syndrome. Neurosciences (Riyadh). 2015 Jan;20(1):4-9.

    PubMed 25630774
  • Yucel H. Factors affecting symptoms and functionality of patients with carpal tunnel syndrome: a retrospective study. J Phys Ther Sci. 2015 Apr;27(4):1097-101. doi: 10.1589/jpts.27.1097. Epub 2015 Apr 30.

    PubMed 25995565

Questions about this trial

What is this clinical trial studying?

An observational study of Carpal Tunnel Syndrome (CTS), run by Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 12 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Müyesser Cavlak, PhD (+905426406118, muyessercavlak@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

median nerve ultrasound (time frame: 3 Months). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07170449, which also lists 9 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in